1. Bone morphogenetic protein-2 and bone therapy: successes and pitfalls. (4th January 2016) Authors: Poon, Bonnie; Kha, Tram; Tran, Sally; Dass, Crispin R Journal: Journal of pharmacy and pharmacology Issue: Volume 68:Number 2(2016:Feb.) Page Start: 139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. C2C12 cell model: its role in understanding of insulin resistance at the molecular level and pharmaceutical development at the preclinical stage. (18th August 2020) Authors: Wong, Chun Y; Al-Salami, Hani; Dass, Crispin R Journal: Journal of pharmacy and pharmacology Issue: Volume 72:Number 12(2020) Page Start: 1667 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cardiomyocyte apoptosis vs autophagy with prolonged doxorubicin treatment: comparison with osteosarcoma cells. (11th September 2014) Authors: Tacar, Oktay; Indumathy, Sivanjah; Tan, Mei Lin; Baindur-Hudson, Swati; Friedhuber, Anna M; Dass, Crispin R Journal: Journal of pharmacy and pharmacology Issue: Volume 67:Number 2(2015:Feb.) Page Start: 231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Delivery of therapeutics for deep-seated ocular conditions – status quo. (19th April 2018) Authors: Nguyen, Hubert; Eng, Shawn; Ngo, Thanh; Dass, Crispin R Journal: Journal of pharmacy and pharmacology Issue: Volume 70:Number 8(2018) Page Start: 994 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Doxorubicin, mesenchymal stem cell toxicity and antitumour activity: implications for clinical use. (22nd January 2018) Authors: Baxter-Holland, Mia; Dass, Crispin R Journal: Journal of pharmacy and pharmacology Issue: Volume 70:Number 3(2018) Page Start: 320 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Issue 1 (2nd January 2016) Authors: Klionsky, Daniel J; Abdelmohsen, Kotb; Abe, Akihisa; Abedin, Md Joynal; Abeliovich, Hagai; Acevedo Arozena, Abraham; Adachi, Hiroaki; Adams, Christopher M; Adams, Peter D; Adeli, Khosrow; Adhihetty, Peter J; Adler, Sharon G; Agam, Galila; Agarwal, Rajesh; Aghi, Manish K; Agnello, Maria; Agostinis... Journal: Autophagy Issue: Volume 12:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. In-vitro evaluation of enteric coated insulin tablets containing absorption enhancer and enzyme inhibitor. (3rd February 2017) Authors: Wong, Chun Y; Martinez, Jorge; Carnagarin, Revathy; Dass, Crispin R Journal: Journal of pharmacy and pharmacology Issue: Volume 69:Number 3(2017:Mar.) Page Start: 285 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Increasing role of the cancer chemotherapeutic doxorubicin in cellular metabolism. (14th March 2016) Authors: Meredith, Ann-Marie; Dass, Crispin R Journal: Journal of pharmacy and pharmacology Issue: Volume 68:Number 6(2016:Jun.) Page Start: 729 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Intraperitoneal delivery of nanoparticles for cancer gene therapy. (January 2013) Authors: Hallaj-Nezhadi, Somayeh; Dass, Crispin R; Lotfipour, Farzaneh Journal: Future oncology Issue: Volume 9:Number 1(2013) Page Start: 59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Metabolic stress and cancer: is autophagy the common denominator and a feasible target?. (17th December 2013) Authors: Giuliani, Charlett M; Dass, Crispin R Journal: Journal of pharmacy and pharmacology Issue: Volume 66:Number 5(2014:May) Page Start: 597 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗